Literature DB >> 25959599

Acquired Immunoglobulin G deficiency in stroke patients and experimental brain ischemia.

Arthur Liesz1, Stefan Roth2, Markus Zorn3, Li Sun4, Kerstin Hofmann2, Roland Veltkamp5.   

Abstract

BACKGROUND AND
PURPOSE: Acute brain injuries induce a systemic immune depression syndrome (SIDS) that predisposes patients to bacterial infections. While cellular compartments of this syndrome have been well characterized, the contribution of humoral immune mechanisms and particularly immunoglobulins to SIDS has not been investigated so far.
METHODS: We determined serum immunoglobulin levels and infectious complications at several time points in 159 ischemic and hemorrhagic stroke patients. Additionally, findings were verified in a transient middle cerebral artery occlusion model. A novel immunoassay was established to analyze the IgG excretion ratio in mice.
RESULTS: We identified a transient IgG reduction in patients suffering from substantial ischemic or hemorrhagic brain injuries. The IgG-reduction was associated with subsequent bacterial infections. Similarly, transient hypogammaglobulinemia was detected in a murine stroke model. We then used this animal model to further distinguish the mechanism of the IgG reduction by an IgG transfer paradigm. Excretional loss rather than deficient production of IgG was demonstrated to underlay hypogammaglobulinemia.
CONCLUSIONS: This is the first report of transient hypogammaglobulinemia after ischemic and hemorrhagic stroke suggesting involvement in infectious complications. These findings pave the road for further studies investigating post-stroke hypogammaglobulinemia as a druggable target for stroke-induced complications.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IgG deficiency; Immunosuppression; Post-stroke infection; Stroke; Translational research

Mesh:

Substances:

Year:  2015        PMID: 25959599     DOI: 10.1016/j.expneurol.2015.04.021

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  7 in total

1.  Antibodies to myelin basic protein are associated with cognitive decline after stroke.

Authors:  Kyra J Becker; Patricia Tanzi; Dannielle Zierath; Marion S Buckwalter
Journal:  J Neuroimmunol       Date:  2016-04-09       Impact factor: 3.478

Review 2.  Infection as a Stroke Risk Factor and Determinant of Outcome After Stroke.

Authors:  Mitchell S V Elkind; Amelia K Boehme; Craig J Smith; Andreas Meisel; Marion S Buckwalter
Journal:  Stroke       Date:  2020-09-08       Impact factor: 7.914

Review 3.  Therapeutic Potential of Intravenous Immunoglobulin in Acute Brain Injury.

Authors:  Vivien Thom; Thiruma V Arumugam; Tim Magnus; Mathias Gelderblom
Journal:  Front Immunol       Date:  2017-07-31       Impact factor: 7.561

4.  Adrenergic-mediated loss of splenic marginal zone B cells contributes to infection susceptibility after stroke.

Authors:  Laura McCulloch; Craig J Smith; Barry W McColl
Journal:  Nat Commun       Date:  2017-04-19       Impact factor: 14.919

5.  Interleukin-1 receptor antagonist treatment in acute ischaemic stroke does not alter systemic markers of anti-microbial defence.

Authors:  Laura McCulloch; Stuart M Allan; Hedley C Emsley; Craig J Smith; Barry W McColl
Journal:  F1000Res       Date:  2019-07-10

Review 6.  Hypothermia and brain inflammation after cardiac arrest.

Authors:  Pouya Tahsili-Fahadan; Salia Farrokh; Romergryko G Geocadin
Journal:  Brain Circ       Date:  2018-04-18

7.  A hyperacute immune map of ischaemic stroke patients reveals alterations to circulating innate and adaptive cells.

Authors:  J R Grainger; C B Lawrence; S Krishnan; C O'Boyle; C J Smith; S Hulme; S M Allan
Journal:  Clin Exp Immunol       Date:  2020-12-09       Impact factor: 5.732

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.